A comprehensive review of the recent developments in DNA repair
that have potential for translational and clinical applications.
The authors explain in detail the various mechanisms by which
cancer cells can circumvent anticancer therapy and limits its
usefulness in patients. They also review the clinical impact of
such novel inhibitors of DNA repair mechanisms as
methylguanine-DNA-methyltransferase. Also examined are inhibitors
of other DNA repair enzymes such as PARP and DNA-PK, now under
development and close to clinical trials. The book captures-for
both cancer researchers and practicing oncologists dealing with
hallmark "relapse" or "drug resistance" phenomena on a daily
basis-the many exciting new uses of DNA repair inhibitors, either
alone or in combination with anticancer therapies.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!